Literature DB >> 10844728

Assessing the relative accuracies of two screening tests in the presence of verification bias.

X H Zhou1, R E Higgs.   

Abstract

Epidemiological studies of dementia often use two-stage designs because of the relatively low prevalence of the disease and the high cost of ascertaining a diagnosis. The first stage of a two-stage design assesses a large sample with a screening instrument. Then, the subjects are grouped according to their performance on the screening instrument, such as poor, intermediate and good performers. The second stage involves a more extensive diagnostic procedure, such as a clinical assessment, for a particular subset of the study sample selected from each of these groups. However, not all selected subjects have the clinical diagnosis because some subjects may refuse and others are unable to be clinically assessed. Thus, some subjects screened do not have a clinical diagnosis. Furthermore, whether a subject has a clinical diagnosis depends not only on the screening test result but also on other factors, and the sampling fractions for the diagnosis are unknown and have to be estimated. One of the goals in these studies is to assess the relative accuracies of two screening tests. Any analysis using only verified cases may result in verification bias. In this paper, we propose the use of two bootstrap methods to construct confidence intervals for the difference in the accuracies of two screening tests in the presence of verification bias. We illustrate the application of the proposed methods to a simulated data set from a real two-stage study of dementia that has motivated this research. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10844728     DOI: 10.1002/(sici)1097-0258(20000615/30)19:11/12<1697::aid-sim455>3.0.co;2-q

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Estimation of the disease-specific diagnostic marker distribution under verification bias.

Authors:  John H Page; Andrea Rotnitzky
Journal:  Comput Stat Data Anal       Date:  2009-01-15       Impact factor: 1.681

2.  Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa.

Authors:  Cynthia Firnhaber; Nomtha Mayisela; Lu Mao; Sophie Williams; Avril Swarts; Mark Faesen; Simon Levin; Pam Michelow; Tanvier Omar; Michael G Hudgens; Anna-Lise Williamson; Bruce Allan; David A Lewis; Jennifer S Smith
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

3.  Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa.

Authors:  Cynthia Firnhaber; Lu Mao; Simon Levin; Mark Faesen; David A Lewis; Bridgette J Goeieman; Avril J Swarts; Ntombiyenkosi Rakhombe; Pam M Michelow; Sophie Williams; Jennifer S Smith
Journal:  J Low Genit Tract Dis       Date:  2015-01       Impact factor: 1.925

4.  Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.

Authors:  Zizipho Z A Mbulawa; Timothy J Wilkin; Bridgette Goeieman; Avril Swarts; Sophie Williams; Simon Levin; Mark Faesen; Jennifer S Smith; Carla J Chibwesha; Anna-Lise Williamson; Cynthia Firnhaber
Journal:  Papillomavirus Res       Date:  2016-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.